China S3 PMS: SAPIEN 3 China Post Market Registry Study

Active, not recruitingOBSERVATIONAL
Enrollment

250

Participants

Timeline

Start Date

January 24, 2022

Primary Completion Date

December 31, 2035

Study Completion Date

December 31, 2035

Conditions
Aortic Stenosis, Severe
Interventions
DEVICE

SAPIEN 3 Transcatheter Heart Valve

Implantation of the SAPIEN 3 valve

Trial Locations (14)

100000

Peking University Third Hospital, Beijing

200000

Shanghai General Hospital, Shanghai

Shanghai Chest Hospital, Shanghai

Xinhua Hospital Affiliated to Shanghai Jiaotong University School of Medicine, Shanghai

310009

The Second Affiliated Hospital Zhejiang University School of Medicine, Hangzhou

361004

Xiamen Cardiovascular Hospital Xiamen University, Xiamen

410000

The Second Xiangya Hospital of Central South University, Changsha

430022

Union Hospital Affiliated to Tongji Medical College of Huazhong University of Science and Technology, Wuhan

450000

Henan Provincial Chest Hospital, Zhengzhou

The First Affiliated Hospital of Zhengzhou University, Zhengzhou

510000

First Affiliated Hospital of Sun Yat-sen University, Guangzhou

710000

The First Affiliated Hospital of Xi'an Jiao Tong University, Xi’an

830000

First Affiliated Hospital of Xinjiang Medical University, Ürümqi

People's Hospital of Xinjiang Uygur Autonomous Region, Ürümqi

Sponsors
All Listed Sponsors
lead

Edwards Lifesciences

INDUSTRY